Viewing Study NCT06445400


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-01-01 @ 5:25 AM
Study NCT ID: NCT06445400
Status: RECRUITING
Last Update Posted: 2025-08-03
First Post: 2024-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module